MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Alcohol Use Disorder in Europe
LA JOLLA, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
AI Turns Vulnerability Management Into a Throughput Problem
Neutrik® Connects Made-To-Order, High-Performance AV Solutions For RCI Custom
AceDraft Announces AceDraft, a Free ATS Resume Tool to Help Gen Z Job Seekers Match Job Descriptions
uSMART Becomes the World’s First Technology Brokerage to Offer Both ‘Night and Pre-Market Trading’ in U.S. Options
Chervon Names Doug Palmer Vice President of Finance – Canada